We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Predicts Cardiac Risk and Mortality from Routine Chest CT Scans

By HospiMedica International staff writers
Posted on 15 May 2024

Heart disease remains the leading cause of death and is largely preventable, yet many individuals are unaware of their risk until it becomes severe. More...

Early detection through screening can reveal heart issues, identifying individuals who may need further examination or potential intervention. While traditional screening methods often measure blood indicators like cholesterol and triglyceride levels, computed tomography (CT) scans can offer a wealth of real-time data about heart health. However, acquiring detailed, quantitative cardiac images usually requires specialized equipment and dyes, making cardiac CT scans costly and not widely used. On the other hand, routine chest CT scans are commonly performed for various reasons, such as checking for lung infections or cancer. Now, a new study has found that these routine CT scans can potentially be used as a screening tool for heart disease.

A collaborative team at Cedars-Sinai Medical Center (Los Angeles, CA, US) is leveraging artificial intelligence (AI) to analyze standard chest CT scans to predict mortality risks. Their research has pinpointed several cardiac indicators within these scans that correlate with a higher risk of death, laying the groundwork for more effective cardiac screenings. The AI system examines images from thousands of patients to automatically extract prognostic features from routine chest CTs—features originally not targeted by these scans. These indicators are then aggregated and analyzed to predict the likelihood of cardiac-related mortality.

Traditionally, cardiac risk is assessed by radiologists identifying abnormalities in imaging. The innovative AI approach has significantly enhanced risk classification beyond this conventional standard. Integrating this AI technology into existing clinical workflows has proved to be simple and has already been implemented at Cedars-Sinai for research purposes. This AI tool is now used to routinely assess CT scans for cardiac prognostic factors. Radiologists typically focused on cancer detections, might not look for cardiac issues such as arterial calcification or chamber enlargement. The AI can assist them by screening these images in the background, identifying patients who may need further cardiac evaluation and potentially early treatment.

“There is a lot of important information that is hiding in chest CT scans,” explained senior study author Piotr Slomka, Ph.D., a professor at Cedars-Sinai. “By using AI to unearth and analyze key prognostic signals in these scans, we could perform opportunistic cardiac screening and potentially prompt treatments or lifestyle changes, which could ultimately save lives.”

Related Links:
Cedars-Sinai Medical Center


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Blood Gas Analyzer
i-Check200
Digital Radiography System (Ceiling Free)
Digix CF Series
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.